Veru (VERU) chief scientist adds 1,800 shares in open-market buy
Rhea-AI Filing Summary
VERU INC. Chief Scientific Officer K. Gary Barnette reported a purchase of 1,800 shares of Veru common stock on 2026-08-13 at an average price of $2.6899 per share in an open-market or private transaction. Following this trade, his directly held position increased to 2,300 shares. The transaction was not marked as being conducted under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,800 shares
Net Buy
1 txn
Insider
BARNETTE K GARY
Role
Chief Scientific Officer
Bought
1,800 shs ($5K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,800 | $2.6899 | $5K |
Holdings After Transaction:
Common Stock — 2,300 shares (Direct)
Key Figures
Shares purchased: 1,800 shares
Purchase price per share: $2.6899 per share
Shares owned after transaction: 2,300 shares
+1 more
4 metrics
Shares purchased
1,800 shares
Common stock bought by K. Gary Barnette on 2026-08-13
Purchase price per share
$2.6899 per share
Average price for the 1,800 VERU shares purchased
Shares owned after transaction
2,300 shares
Directly held VERU common stock by K. Gary Barnette after the trade
Transaction date
2026-08-13
Date of the reported common stock purchase
Key Terms
Rule 10b5-1, open market or private transaction, Form 4
3 terms
Rule 10b5-1 regulatory
"The transaction was not marked as being conducted under a Rule 10b5-1 trading plan"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open market or private transaction market
"transaction_code_description: Purchase in open market or private transaction"
Form 4 regulatory
"K. Gary Barnette reported this transaction on a Form 4 insider report"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did VERU Chief Scientific Officer report?
VERU Chief Scientific Officer K. Gary Barnette reported buying 1,800 shares of Veru common stock on 2026-08-13 at $2.6899 per share, increasing his directly held stake to 2,300 shares after the transaction.
Was the VERU insider trade under a Rule 10b5-1 trading plan?
No. The Form 4 for VERU shows the Rule 10b5-1 checkbox as not selected, indicating the 1,800-share purchase on 2026-08-13 was not reported as pursuant to a Rule 10b5-1 trading plan.
What type of transaction is reported in VERU’s latest Form 4?
The latest VERU Form 4 reports a purchase of common stock by Chief Scientific Officer K. Gary Barnette. It is coded as a P transaction, meaning a purchase in an open market or private transaction rather than a derivative exercise.
AI-generated analysis. How Rhea-AI works. Not financial advice.
